Antony A Riley Forte Biosciences, Inc. (FBRX) insider trading activity

Antony A Riley is CHIEF FINANCIAL OFFICER of Forte Biosciences, Inc.. Currently has a direct ownership of 31,218 shares of FBRX, which is worth approximately $255,987. The most recent transaction as insider was on Apr 01, 2025, when has been sold 154 shares (Common Stock) at a price of $7.43 per share, resulting in proceeds of $1,144. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.2K

0.71% 3M change

83.95% 12M change

Total Value Held $255,987

Antony A Riley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2025	SELL Payment of exercise price or tax liability	$1,144 $7.43 p/Share	154 Reduced 0.49%	31,218 Common Stock
Apr 01 2025	BUY Exercise of conversion of derivative security	-	375 Added 1.18%	31,372 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$3,497 $22.71 p/Share	154 Reduced 0.49%	30,997 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	375 Added 1.19%	31,151 Common Stock
Nov 21 2024	BUY Open market or private purchase	$124,952 $5.55 p/Share	22,514 Added 42.25%	30,776 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$686 $5.16 p/Share	133 Reduced 1.58%	8,262 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	-	375 Added 4.28%	8,395 Common Stock
Jul 01 2024	SELL Payment of exercise price or tax liability	$1,839 $0.55 p/Share	3,345 Reduced 1.64%	200,504 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	-	9,375 Added 4.4%	203,849 Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$2,374 $0.71 p/Share	3,345 Reduced 1.69%	194,474 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	-	9,375 Added 4.52%	197,819 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$3,149 $0.82 p/Share	3,841 Reduced 2.0%	188,444 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	9,375 Added 4.65%	192,285 Common Stock
Oct 01 2023	SELL Payment of exercise price or tax liability	$2,139 $0.66 p/Share	3,241 Reduced 1.74%	182,910 Common Stock
Oct 01 2023	BUY Exercise of conversion of derivative security	-	9,375 Added 4.79%	186,151 Common Stock
Jul 31 2023	BUY Grant, award, or other acquisition	$149,999 $1.01 p/Share	148,514 Added 45.66%	176,776 Common Stock
Jul 01 2023	SELL Payment of exercise price or tax liability	$3,370 $1.04 p/Share	3,241 Reduced 11.57%	24,762 Common Stock
Jul 01 2023	BUY Exercise of conversion of derivative security	-	9,375 Added 25.08%	28,003 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$3,273 $1.01 p/Share	3,241 Reduced 14.82%	18,628 Common Stock
Apr 01 2023	BUY Exercise of conversion of derivative security	-	9,375 Added 30.01%	21,869 Common Stock
Sep 07 2021	SELL Open market or private sale	$106,500 $4.26 p/Share	25,000 Reduced 69.32%	11,065 Common Stock

AAR

Antony A Riley

CHIEF FINANCIAL OFFICER

Torrance, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FBRX shares.

Notify only if

Value

Insider Trading

Get notified when an Forte Biosciences, Inc. insider buys or sells FBRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Forte Biosciences, Inc.

Track Activities on FBRX

Account